Tags
Subscribe
Subscribe
News
Schools
Business
Obituaries
Police & Fire
Weather
Neighbors
Lifestyle
Politics
Sports
Events
Traffic
Legal
Real Estate
Tags
Jobs
Shop
Support Us
Subscribe
News
Schools
Business
Obituaries
Police & Fire
Weather
Neighbors
Lifestyle
Politics
Sports
Events
Traffic
Legal
Real Estate
Readers Choice
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2026 Cantata Media
Worcester, MA
News
Covid-
19: This Is When Children Can Start Getting The Vaccine, Fauci Says
An estimated timeline for when children and teens will be able to get COVID-19 vaccinated was recently laid out by Dr. Anthony Fauci. Some of the youngest children won’t be vaccinated until 2022. On Sunday, Feb. 28, Fauci, head of the National Institute of Allergy and Infectious Diseases, said that high school students could begin receiving the vaccine in the fall. Younger children, he said, will likely have to wait until early next year. During an interview on NBC’s “Meet the Press” Fauci said that more research needs to be done to make sure the available COVID-19 vaccines are safe for…
Torrington, CT
News
Covid-
19: Here's How Many Doses Of New Johnson & Johnson Vaccine CT Will Get, Lamont Announces
Tens of thousands of the Johnson & Johnson COVID-19 vaccine have been earmarked for Connecticut, provided it gains federal approval for emergency use by an oversight committee, possibly as soon as this weekend. This week, the Food and Drug administration staff endorsed the new vaccine, which would only require one dose and is easier to store than the current Pfizer and Moderna vaccines. Earlier story - COVID-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use If approved by the FDA’s Vaccines and Related Biological Products Advisory Committee on F…
Shelton, CT
News
Covid-
19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use
The Food and Drug Administration's staff has endorsed Johnson & Johnson’s COVID-19 vaccine for emergency use, paving the way for the one-dose shot to receive its final approval for emergency use in America by a final committee. This week, the FDA announced it supported the approval of the vaccine, which is easier to store and would represent a third vaccination option for those looking to get inoculated as the country combats the virus. The FDA’s Vaccines and Related Biological Products Advisory Committee is expected to meet on Friday, Feb. 26 to determine whether the new vaccine is via…
Worcester, MA
News
Covid-
19: Not Enough Vaccine In US For Everyone Right Now, Fauci Says
The U.S. doesn’t have enough of the COVID-19 vaccine to innoculate everybody right now and likely won’t have the appropriate supplies for months to come, said Dr. Anthony Fauci. This announcement signals a pushed-back timeframe for when the COVID-19 vaccine will be readily available to the public. Widespread availability is now expected in May or June, he said. Originally, Fauci had hoped there would be enough vaccine available for the U.S. population to have easy access to COVID-19 inoculations by the end of April. So far, 55.2 million vaccines - out of a 71.6 million supply - have been …
Brookfield, CT
News
Covid-
19: Johnson & Johnson Releases Trial Results For One-Dose Vaccine
Some relief may be on the way for the millions of people awaiting their turn to receive the COVID-19 vaccine. Johnson & Johnson has been developing a single-dose vaccine for COVID-19, which has an efficacy rate of approximately 72 percent, potentially bringing another provider into the mix as vaccines for the virus have become a valuable and scarce commodity. If it is ultimately approved by federal health officials, the Johnson & Johnson vaccine would join Pfizer and Moderna on the market, both of which require two doses administered approximately three weeks apart. However, the ef…
New City, NY
Lifestyle
What’s In The
Covid-
19 Vaccine?
The COVID vaccines being rolled out do not use inactive virus to build immunity, rather messenger RNA (mRNA) technology as a novel way of preventing illness Sandra Lindsay’s bravery and wisdom spoke volumes when she became the first person in the US to receive the COVID-19 vaccine. “Healing is coming,” she said directly after getting the shot, iconic yet profound words that will ultimately propel the country—and world—through the final stages of the pandemic. It’s even more historic considering how the COVID vaccine works. The vaccines currently being rolled out from Pfizer Inc. and Mo…
Briarcliff, NY
Lifestyle
What’s In The
Covid-
19 Vaccine?
The COVID vaccines being rolled out do not use inactive virus to build immunity, rather messenger RNA (mRNA) technology as a novel way of preventing illness Sandra Lindsay’s bravery and wisdom spoke volumes when she became the first person in the US to receive the COVID-19 vaccine. “Healing is coming,” she said directly after getting the shot, iconic yet profound words that will ultimately propel the country—and world—through the final stages of the pandemic. It’s even more historic considering how the COVID vaccine works. The vaccines currently being rolled out from Pfizer Inc. and Mo…
Hackensack, NJ
News
Covid-
19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective
More reliable than the flu shot? Pfizer on Monday trumpeted a COVID-19 vaccine candidate as more than 90% effective – nearly three times better than the effectiveness of last season’s influenza vaccine. Pfizer said it hopes to have 50 million doses of the free vaccine ready by the end of this year and as many as 1.3 billion doses available next year to fight the deadly global pandemic. Two doses per person of BNT162b2 would be necessary, said the Manhattan-based drug maker, which teamed up with BioNTech of Germany to develop the booster. Pfizer plans to ask the federal Food and Drug Admini…
Edison, NJ
News
J&J: Mystery Illness Pauses Largest COVID Vaccine Trial
A mystery illness suffered by a participant has put the largest COVID-19 vaccine trial on hold, drug maker Johnson & Johnson announced. The New Jersey-based company – which sought 60,000 volunteers mostly over 60 – didn’t describe the illness or identify the patient in any way. “We must respect this participant's privacy,” J&J said in a statement. “We're also learning more about this participant's illness, and it's important to have all the facts before we share additional information.” J&J said it would provide transparent updates throughout the development of the randomized, …
Edison, NJ
News
Nj-b
ased Johnson & Johnson Pauses
Covid-
19 Vaccine Trial Due To Unexplained Participant Illness
New Jersey-based Johnson & Johnson has paused its COVID-19 vaccine study because of an unexplained illness among a participant. Researchers running the 60,000 patient trial received a notice saying the "pausing rule has been met," Stat News reports. The online patient-enrolling system was subsequently closed and a meeting for the patient safety monitoring board comprised of independent committee met Monday evening, the report says. J&J -- based in New Brunswick -- declined to tell Stat News anything more than a study participant suffered an unexplained illness. The company began e…
Edison, NJ
News
Punitive Damages: J&J Must Pay $185M In Mesothelioma Case Involving Baby Powder
Jurors in New Brunswick on Thursday rendered a $750 million punitive damages verdict against Johnson & Johnson on behalf of four people who allegedly got mesothelioma from its baby powder – and a judge immediately cut the award to $185 million, NJ.LAW reported. Johnson & Johnson vowed to appeal. The jury deliberated for less than a day following a three-week trial, the site reported. The punitive damages will be added to $37 million compensatory damages verdict rendered last September by a separate jury. They go to plaintiffs Douglas Barden and his wife, Roslyn Barden; David Ethri…
Shelton, CT
News
Johnson & Johnson Recalls Baby Powder After Asbestos Found
Johnson & Johnson announced a voluntary recall of 33,000 bottles due to low levels of potential asbestos contamination. The recall, which is limited to lot #22318RB, were produced and shipped nationwide last year. It comes after the US Food and Drug Administration test that found levels of chrysotile asbestos contamination in samples from a bottle purchased online, according to the company. According to Johnson & Johnson, the FDA test indicated the presence of sub-trace levels of chrysotile asbestos contamination - no greater than 0.00002 percent - in samples from a single bottle pu…
Archive
